Despite an array of laboratory findings suggesting that COVID-19 patients with G6PD deficiency may suffer a worse prognosis, one clinical study concluded that G6PD-deficient patients might experience less severe symptoms, requiring reduced ventilatory support and an overall lower case-fatality rate than patients with in-tact G6PD [11]. The gene discussed is G6PD; the disease is G6PD deficiency.